Liver transplantation for hepatitis B in the United States

被引:13
作者
Camci, C [1 ]
Gurakar, A [1 ]
Rose, J [1 ]
Rizvi, S [1 ]
Wright, H [1 ]
Bader, T [1 ]
Monlux, R [1 ]
Schade, RR [1 ]
Nour, BM [1 ]
Sebastian, A [1 ]
机构
[1] Integris Baptist Med Ctr, Nazih Zuhdi Transplant Inst, Oklahoma City, OK 73112 USA
关键词
D O I
10.1016/j.transproceed.2005.10.017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Aim. To evaluate the impact of hepatitis B virus (HBV) on US health care system, we reviewed the Organ Procurement and Transplantation (OPTN, formerly UNOS) HBV database. Method. We reviewed records of liver transplantations (LTx) performed in the United States listed for the diagnoses of HBV between 1993 and mid-October 2004. Both acute as well as chronic cases were included. Coinfection with hepatitis C virus was excluded from study. The specific states selected for review were chosen from those areas that are receiving large numbers of new immigrants from high HBV endemic areas (ie, Texas, Pennsylvania, California, New York, and Florida). One-, 3-, and 5-year patient survival rates for both cadaveric and living related donors were analyzed. Survival rates were obtained from OPTN database as Kaplan-Meyer survival test. Results. Between 1993 and mid-October 2004, 53,312 LTx had been performed nationwide. Of these, 2314 (4.34%) were performed for the diagnosis of HBV; 1816 cases (78%) were due to chronic HBV infection (45 of them were living donor LTx) and 498 cases (22%) were due to HBV-induced acute liver failure (seven of them were living donor LTx). Three- and 5-year survival rates of chronic HBV-related LTx patients were better than acute HBV-related and overall LTx patients. Conclusion. HBV is generally considered to have a minor health significance by many community gastroenterologists. With growing immigration from overseas, it may eventually have a higher impact on LTx. Therefore, it is crucial to further educate gastroenterologists and primary care physicians caring for this specific group of patients.
引用
收藏
页码:4350 / 4353
页数:4
相关论文
共 10 条
[1]   Efficacy of lamivudine therapy for advanced liver disease in patients with precore mutant hepatitis B virus infection awaiting liver transplantation [J].
Andreone, P ;
Biselli, M ;
Gramenzi, A ;
Cursaro, C ;
Morelli, MC ;
Sama, C ;
Lorenzini, S ;
Spinucci, G ;
Porzio, F ;
Felline, F ;
Di Giammarino, L ;
Bernardi, M .
TRANSPLANTATION, 2002, 74 (08) :1119-1124
[2]   New era of liver transplantation for hepatitis B - A 17-year single-center experience [J].
Anselmo, DM ;
Ghobrial, RM ;
Jung, LC ;
Weaver, M ;
Cao, C ;
Saab, S ;
Kunder, G ;
Chen, PW ;
Farmer, DG ;
Yersiz, H ;
Baquerizo, A ;
Geevarghese, S ;
Han, SH ;
Goldstein, L ;
Holt, CD ;
Gornbein, JA ;
Busuttil, RW .
ANNALS OF SURGERY, 2002, 235 (05) :611-619
[3]   Hepatitis B and hepatitis C viruses in liver transplantation [J].
Curry, MP .
TRANSPLANTATION, 2004, 78 (07) :955-963
[4]   Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine [J].
Di Marco, V ;
Marzano, A ;
Lampertico, P ;
Andreone, P ;
Santantonio, T ;
Ahnasio, PL ;
Rizzetto, M ;
Craxì, A .
HEPATOLOGY, 2004, 40 (04) :883-891
[5]  
Dianzani F, 1999, J BIOL REG HOMEOS AG, V13, P71
[6]   Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation [J].
Holt, D ;
Thomas, R ;
Van Thiel, D ;
Brems, JJ .
ARCHIVES OF SURGERY, 2002, 137 (05) :572-575
[7]   Outcome of liver transplantation for hepatitis B in the United States [J].
Kim, WR ;
Poterucha, JJ ;
Kremers, WK ;
Ishitani, MB ;
Dickson, ER .
LIVER TRANSPLANTATION, 2004, 10 (08) :968-974
[8]   Medical progress - Hepatitis B virus infection [J].
Lee, WM .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (24) :1733-1745
[9]  
LOK ASF, 2004, AAS D PRACTICE GUIDE, P13
[10]  
MCQUILLAN GM, 1989, AM J MED, V87, pS5